Figure 1From: Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapyBox plots showing distributions of NLR values according to the tumor response. (1) Pre-treatment NLR. (2) Post-treatment NLR. (3) % Changes in post-treatment NLR.Back to article page